Upadacitinib

Rinvoq

Janus Kinase Inhibitor

NADAC/unit $228.8254

No Shortage Tier 1: 66.6% PA Req: 369.9%

vs. brand Rinvoq: Generic saves up to -2188% per unit

Covered Lives

Generic Manufacturers

ABBVIE INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Upadacitinib drfinder.aiFind doctors who prescribe Upadacitinib rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Upadacitinib

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.